Menu Close

FDA Examines Infant Formula Labels

Here’s an item of interest that may have gone unnoticed: The Food and Drug Administration (FDA) last week issued a call for public comment on a proposed study of infant formula label statements, such as “supports brain and eye development.”

According to its posting in the Federal Register, the purpose of the study is to “assess women’s understanding of and response to various statements on infant formula labels.” The study will involve a survey of four groups:

  • pregnant women
  • mothers of infants less than 12 months old
  • mothers of children >1 and <5 years old
  • women of childbearing age with no children <5 years old

An online consumer panel will randomly select 5,000 participants who meet this criteria; for more details about study details, including what types of questions will be included, see the agency’s notice. The results will “help the Agency understand the role that certain types of statements on infant formula labels have in influencing choice.”

If you are concerned about the addition of DHA and ARA to infant formula and support the FDA’s proposed study, let them know before May 2nd. Submit comments electronically or send them to Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments must refer to Docket No. FDA-2011-N-0098.

Share this

1 Comment

  1. Derick Borden

    Do you mind if I quote a few of your posts as long as I provide credit and sources back to your website? My blog site is in the very same area of interest as yours and my visitors would definitely benefit from a lot of the information you provide here. Please let me know if this okay with you. Appreciate it!. The Flowered Corner, 110 Ladbroke Grove, London, W10 5NE Phone: 020 7221 3320

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.